Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 471 - 480 of 975

COVID-19 Resource Directory (PDF - 278 KB)

This directory includes a comprehensive list of state and federal COVID-19 resources.

Format
Other
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
States
Source
Federation of State Medical Boards
Year
Resource Type
PDF

COVID-19 Telehealth Toolkit (PDF - 573 KB)

This toolkit is curated to help both providers and patients understand more about the benefits of telehealth during the COVID-19 pandemic, as well as understanding the coverage telehealth provides.

Format
Toolkit
Audience
Medical Providers
Organizational Leadership
Other Team Members
Practice Facilitators/Quality Improvement Coaches
Source
National Consortium of Telehealth Resource Centers
Year
Resource Type
PDF

CRAFFT

This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of this well-validated and widely-utilized adolescent substance use screening tool to accurately identify adolescents at risk for a substance use disorder. It also presents new recommended clinician talking points, informed by the latest science and clinician feedback.

Format
Instrument/Protocol
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Car, Relax, Alone, Forget, Friends, Trouble (CRAFFT)
Year
Resource Type
Web Page

Criminal Justice DrugFacts

This NIDA web page includes facts and figures on addressing substance use disorders in the prison population.
Format
Web Page
Audience
States
Policymakers and Payers
Other Team Members
Communities
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Ensuring appropriate quality, access, and utilization of digital therapeutics (PDF - 189 KB)

This worksheet provides recommendations for patients, clinicians, and payors, on how to ensure digital therapeutic quality, access, and utilization when considering mental health apps, including those for substance use.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Source
Digital Therapeutics Alliance (DTA)
Year
Resource Type
PDF

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency (PDF - 201 KB)

SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance on the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency for Opioid Treatment Programs.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
States
Source
Substance Abuse and Mental Health Services Administration
Year
Resource Type
PDF

Framing Opioid Prescribing Guidelines for Acute Pain (PDF - 7.8 MB)

This guideline develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications and recommends indications for which new evidence-based guidelines should be developed.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
The National Academies of Sciences, Engineering, and Medicine
Year
Resource Type
PDF